| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.03 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.04 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |